| Mary Patricia Holzbauer, CSW | |
|
1201 Jackson St, Marinette County Health And Human Services, Niagara, WI 54151 | |
| (715) 732-7760 | |
| (715) 732-7711 |
| Full Name | Mary Patricia Holzbauer |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 1201 Jackson St, Niagara, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447385133 | NPI | - | NPPES |
| 3469120 | Other | WI | CSW |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 3469120 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mary Patricia Holzbauer, CSW 2500 Hall Ave, Suite A Marinette County Health And Human Services, Marinette, WI 54143 Ph: (715) 732-7760 | Mary Patricia Holzbauer, CSW 1201 Jackson St, Marinette County Health And Human Services, Niagara, WI 54151 Ph: (715) 732-7760 |
News Archive
The use of sentinel lymph node biopsy (SLNB) during breast cancer surgery increased substantially from 1998 through 2005, according to an article published online March 25 in the Journal of the National Cancer Institute.
Self-weighing can be a useful tool to help adults control their weight, but for adolescents and young adults this behavior may have negative psychological outcomes. Researchers from the University of Minnesota tracked the self-weighing behaviors of more than 1,900 young adults as part of Project EAT (Eating and Activity in Teens and Young Adults) and found increases in self-weighing to be significantly related to increases in weight concern and depression and decreases in body satisfaction and self-esteem among females.
Patients with coronary heart disease who took Lipitor (atorvastatin calcium) 80 mg tablets reduced their risk of hospitalizations due to heart failure compared to patients taking the 10 mg dose of Lipitor, according to a new analysis of a subset of patients from the five-year TNT (Treating to New Targets) study, published in today's issue of Circulation.
XBiotech, a privately held biotechnology company, announced positive interim analysis results today from a Phase II study using a True Human monoclonal antibody (MABp1) in patients with type 2 diabetes. Results from this study continue to reinforce the role of IL-1α as a master regulator of chronic inflammation in multiple disease states, and the therapeutic benefits of neutralizing antibodies produced from the XBiotech platform.
› Verified 6 days ago
Gilbert Corbin Engel, MSW LCSW ACSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1249 Garfield St, Niagara, WI 54151 Phone: 715-251-3300 |